SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717 

SEC Filing Details

Document Details

Filing Date
Dec 23, 2013
Document Date
Dec 23, 2013
Form Description
Tender offer schedule and amendment filed by a third party.
Filing Group
Mergers & Acquisitions
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC